ARID1A mutations in cancer development: mechanism and therapy
Carcinogenesis · 27.05.2023 · 44 (3) · 197-208
DOI: 10.1093/carcin/bgad011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Carcinogenesis, online erschienen am 06.03.2023. Verfasst von Xuewei Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Hospital of China Medical University, Shenyang, 110001, China. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: Department of Science and Technology of Liaoning Province.
Abstract (Originalsprache)
AT-Rich Interaction Domain 1A (ARID1A) is an important SWItch/Sucrose Non-Fermentation (SWI/SNF) chromatin remodeling complex subunit, and its coding gene has a high mutation frequency in many cancers. Current studies have reported that ARID1A mutational status is correlated to cancer development, including cell proliferation, invasiveness, metastasis, and morphological alterations. ARID1A acts as a tumor suppressor, regulating gene transcription, participating in DNA damage response, and influencing tumor immune microenvironment and signaling pathways. The absence of ARID1A in cancer can lead to widespread dysregulation of gene expression in cancer initiation, promotion, and progression. For patients with ARID1A mutations, effective individualized treatment can improve the prognosis of patients. In this review, we aim to discuss the mechanism of ARID1A mutations in cancer development and explore the significance of discoveries for treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, The First Hospital of China Medical University, Shenyang, 110001, China.
- Department of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, 110001, China.
ORCID-Profile: Wenjing Shen
Förderung
- Department of Science and Technology of Liaoning Province
Zitieren
APA
Zhang, X., Zhang, Y., Zhao, J., Wu, Y., Zhang, N., & Shen, W. (2023). ARID1A mutations in cancer development: mechanism and therapy. Carcinogenesis, 44(3), 197-208. https://doi.org/10.1093/carcin/bgad011
Vancouver
Zhang X, Zhang Y, Zhao J, Wu Y, Zhang N, Shen W. ARID1A mutations in cancer development: mechanism and therapy. Carcinogenesis. 2023;44(3):197-208. doi:10.1093/carcin/bgad011
BibTeX
@article{Zhang2023,
author = {Zhang, Xuewei and Zhang, Yixuan and Zhao, Jinyi and Wu, Yinjie and Zhang, Na and Shen, Wenjing},
title = {ARID1A mutations in cancer development: mechanism and therapy},
journal = {Carcinogenesis},
year = {2023},
volume = {44},
number = {3},
pages = {197--208},
doi = {10.1093/carcin/bgad011}
}
EUVIMED